![PharmCADD](https://storage.googleapis.com/dealroom-images-production/17/MTAwOjEwMDpjb21wYW55QHMzLWV1LXdlc3QtMS5hbWF6b25hd3MuY29tL2RlYWxyb29tLWltYWdlcy8yMDI0LzA3LzA0LzQ2MDJlYzk5YmZlMDE3YTI3ZjA3NDU3ZjlkMTIwNTY3.png)
PharmCADD
VerifiedCombines deep learning approaches with molecular dynamics simulation and quantum calculation to create cutting-edge computational modules.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$64—96m (Dealroom.co estimates Apr 2021.)
Company register number 2848601260
Busan South Korea (HQ)
USD | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 |
% growth | - | 100 % | 57 % | - |
EBITDA | 0000 | 0000 | 0000 | 0000 |
Profit | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 |
Get premium to view all results
Date | Investors | Amount | Round |
---|---|---|---|
N/A | $0.0 | round | |
N/A | $0.0 | round | |
$16.0m | Series B | ||
Total Funding | 000k |
Related Content
Recent News about PharmCADD
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.